The Activated Seven Lupus Anticoagulant (ASLA) assay: A new test for lupus anticoagulants (LAs). Evidence that some LAs are detectable only in extrinsic pathway-based assays

Blood Coagulation and Fibrinolysis

Volumn 13, Issue 3, 2002, Pages 261-269

  Moore, G W ^a   Smith, M P ^a   Patel, Y ^a   Savidge, Geoffrey F ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Extrinsic pathway; Lupus anticoagulant; Recombinant FVIIa

Indexed keywords

LUPUS ANTICOAGULANT; PHOSPHOLIPID; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; BLOOD SAMPLING; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DILUTION; DRUG DETERMINATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PRIORITY JOURNAL; PROGNOSIS; SCREENING TEST; SENSITIVITY ANALYSIS; THROMBOSIS;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; BRAIN CHEMISTRY; FACTOR VIIA; HUMANS; LUPUS COAGULATION INHIBITOR; PHOSPHOLIPIDS; RECOMBINANT FUSION PROTEINS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0036526354     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200204000-00013     Document Type: Article

References (26)

1. Lupus anticoagulants: Pathogenesis and laboratory diagnosis
2. The antiphospholipid thrombosis syndromes: A common multidisciplinary medical problem
3. New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies
4. Guidelines on the investigation and management of the antiphospholipid syndrome
5. Criteria for the diagnosis of lupus anticoagulants: An update
6. Frequent difficulties encountered in the laboratory diagnosis of antiphospholipid-protein antibodies
7. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK national external quality control scheme (NEQAS) for blood coagulation
8. Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working party on behalf of the BCSH Haemostasis and Thrombosis Task Force
9. The Taipan snake venom time: A new test for lupus anticoagulant
10. A hexagonal (II) phase phospholipid neutralization assay for lupus anticoagulant detection
11. A clinical study of the lupus anticoagulant
12. Evaluation of recently described tests for detection of the lupus anticoagulant
13. The importance of locally derived reference ranges and standardized calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant
14. The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers
15. Strategies for the scientific definition of the terms 'reliability' and 'predictability' of clinical and laboratory findings
16. Tissue factor and factor FVII initiation of coagulation
17. Measurement of basal levels of factor VIIa in Haemophilia A and B patients
18. Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease
19. Platelet activity of high-dose factor VIIa is independent of tissue factor
20. An evaluation of two commercial test procedures for the detection of lupus anticoagulant
21. Evaluation of sensitivity and specificity of a standardised procedure using different reagents for the detection of lupus anticoagulants
22. Three lupus anticoagulant kits
23. Optimization of the dilute prothrombin time for the detection of the lupus anticoagulant by use of a recombinant tissue thromboplastin
24. Antiphospholipid syndrome: Diagnostic aspects of lupus anticoagulants
25. Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time
26. Transient lupus anticoagulants in children: Stepwise disappearance of diagnostic features